In-vitro cytotoxicity of ET-743 (Trabectedin, Yondelis), a marine anti-cancer drug, in the Hep G2 cell line: influence of cytochrome P450 and phase II inhibition, and cytochrome P450 induction (Q40373456)
Jump to navigation
Jump to search
scientific article published on October 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In-vitro cytotoxicity of ET-743 (Trabectedin, Yondelis), a marine anti-cancer drug, in the Hep G2 cell line: influence of cytochrome P450 and phase II inhibition, and cytochrome P450 induction |
scientific article published on October 2005 |
Statements
1 reference
In-vitro cytotoxicity of ET-743 (Trabectedin, Yondelis), a marine anti-cancer drug, in the Hep G2 cell line: influence of cytochrome P450 and phase II inhibition, and cytochrome P450 induction (English)
1 reference
Jos H Beijnen
1 reference
Jan H M Schellens
1 reference
Esther F A Brandon
1 reference
Irma Meijerman
1 reference
Joyce S Klijn
1 reference
Dineke den Arend
1 reference
Rolf W Sparidans
1 reference
Louis López Lázaro
1 reference
1 October 2005
1 reference
1 reference
Identifiers
1 reference